tiprankstipranks
NextCell Pharma AB (DE:65G)
FRANKFURT:65G
Germany Market
65G
NextCell Pharma AB
RESEARCH TOOLSreports

NextCell Pharma AB (65G) Cash flow

0 Followers

NextCell Pharma AB Cash Flow

DE:65G's free cash flow for Q1 2026 was kr-25.32M. For the 2026 fiscal year, DE:65G's free cash flow was decreased by kr-5.18M and operating cash flow was kr-22.81M. See a summary of the company’s cash flow.
Cash Flow
Aug 25Aug 24Aug 23Aug 22Aug 21
Operating Cash Flow
kr -38.86Mkr -37.78Mkr -43.83Mkr -33.31Mkr -25.58M
Investing Cash Flow
kr -4.24Mkr -83.51Kkr -4.10Mkr -9.37Mkr -5.84M
Financing Cash Flow
kr 35.03Mkr 34.63Mkr 835.66Kkr 608.17Kkr 148.63M
End Cash Position
kr 38.72Mkr 46.79Mkr 50.03Mkr 97.12Mkr 139.17M
Free Cash Flow
kr -43.05Mkr -37.86Mkr -47.92Mkr -40.90Mkr -26.30M
Currency in SEK

NextCell Pharma AB Cash Flow